GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $51.99 $51.99 Friday, 27th Jan 2023 CCXI stock ended at $51.99. During the day the stock fluctuated 0% from a day low at $51.99 to a day high of $51.99.
90 days $51.99 $51.99
52 weeks $14.95 $52.00

Historical ChemoCentryx prices

Date Open High Low Close Volume
2022-09-02 $51.50 $51.78 $51.39 $51.42 1 600 621
2022-09-01 $51.06 $51.73 $51.05 $51.63 2 184 021
2022-08-31 $51.14 $51.22 $50.96 $50.98 1 280 358
2022-08-30 $51.09 $51.19 $50.93 $51.02 2 474 191
2022-08-29 $51.05 $51.26 $50.98 $51.03 1 522 757
2022-08-26 $51.10 $51.21 $51.01 $51.17 1 678 503
2022-08-25 $51.10 $51.19 $51.00 $51.05 1 637 687
2022-08-24 $50.95 $51.12 $50.91 $51.00 1 970 115
2022-08-23 $50.97 $51.10 $50.86 $50.92 2 275 962
2022-08-22 $50.91 $51.06 $50.86 $51.00 2 131 675
2022-08-19 $50.90 $51.11 $50.86 $51.00 2 539 562
2022-08-18 $50.90 $51.00 $50.82 $51.00 2 672 632
2022-08-17 $50.85 $51.37 $50.75 $50.78 3 385 273
2022-08-16 $50.82 $51.24 $50.80 $50.86 2 615 192
2022-08-15 $50.69 $50.86 $50.62 $50.81 3 332 684
2022-08-12 $50.75 $50.80 $50.58 $50.72 2 891 602
2022-08-11 $50.85 $51.06 $50.59 $50.60 6 479 749
2022-08-10 $50.68 $50.93 $50.67 $50.87 3 889 905
2022-08-09 $50.69 $50.94 $50.56 $50.79 8 318 366
2022-08-08 $50.42 $50.91 $50.40 $50.89 5 879 453
2022-08-05 $50.44 $50.79 $50.36 $50.52 7 775 873
2022-08-04 $50.25 $50.90 $49.96 $50.43 36 142 919
2022-08-03 $23.63 $25.09 $23.59 $24.11 1 120 756
2022-08-02 $22.56 $23.74 $22.50 $23.27 555 254
2022-08-01 $23.49 $24.39 $22.40 $22.62 904 439
Click to get the best stock tips daily for free!

About ChemoCentryx

ChemoCentryx ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of... CCXI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT